UICC Opens the World Cancer Leaders’ Summit 2025

World Cancer Leaders UICC

“Delivering Innovation with Integrity” - ACT 4 Children Initiative at the 2025 WCLS

ACT 4 Children

Top Growing Medical Universities in USA and Canada: 2025 Edition by BIGR

USA and Canada

2025 Selected Abstracts for the European Cancer Summit - European Cancer Organisation

European Cancer Organisation European Cancer Summit

FDA Approves Ziftomenib (Komzifti) for Relapsed or Refractory NPM1-Mutated Acute Myeloid Leukemia

ziftomenib

10 Oncology Experts Join OncoDaily Medical Journal’s Editorial Team

OncoDaily Medical Journal

The World’s First Trial of a Vaccine to Prevent Lung Cancer - Cancer Research UK

Cancer Research UK

Pediatric Cardio-Oncology Consortium to Host Virtual Summit on December 4, 2025

Cardio-Oncology-Consortium

OncoCalendar

« All Events

  • This event has passed.

LATAM Course II: Immunotherapy in Lung Cancer by IASLC

Dec 19, 2024 • 4:00 PM - 5:00 PM
LATAM Course II: Immunotherapy in Lung Cancer by IASLC

LATAM Course II: Immunotherapy in Lung Cancer by IASLC will be held at December 19th, 2024.

The exclusive course on the latest updates in lung cancer treatment in LATAM, with a special focus on immunotherapy, will take place in Series II. Renowned thoracic oncology experts from the region will explore the role of immunotherapy in revolutionizing lung cancer care. The discussions will cover crucial topics, including the integration of biomarkers for immunotherapy, optimal management strategies for advanced disease, and addressing challenges like pneumonitis. Participants will have the opportunity to explore how immunotherapy will transform the landscape of lung cancer treatment in LATAM, offering hope for improved patient outcomes.

See the Speakers and Series II LATAM Team Below:

LATAM Course II: Immunotherapy in Lung Cancer by IASLC

Details

Organizer